Monossacáridos

D-Glucoheptonic acid-1,4-lactone is a chiral compound that can be used as an enantiomer of the natural sugar glucose. The human liver has been shown to metabolize this compound into proton and an analog of glucofuranose. This means that D-Glucoheptonic acid-1,4-lactone is able to be broken down by glycosidases. D-Glucoheptonic acid-1,4-lactone also inhibits α-L-rhamnosidase and other enzymes responsible for the breakdown of carbohydrates. This inhibition may lead to increased blood glucose levels in humans. D-Glucoheptonic acid-1,4-lactone has been shown to have inhibitory activities against both bacterial and mammalian enzymes. Hydrogen fluoride (HF) was used as a catalyst in the synthesis of this compound with benzylidene acetal

2-Iodoethyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside is a high purity custom synthesis that can be modified with Click chemistry. It can be synthesized by modification of methylated glycosides and saccharides. This product has been shown to have a wide range of applications in the areas of fluorination, glycosylation, and methylation. The sugar moiety is an oligosaccharide made up of one or more monosaccharides (simple sugars) joined together by glycosidic bonds. This product is often found in complex carbohydrates such as glycogen and starch.

2,3,4-Tri-O-acetyl-a-D-xylopyranosyl bromide - Stabilised with 2.5% CaCO3 is a chiral compound that is a drug for the treatment of estrogen deficiency in postmenopausal women. It is synthesized from D-xylose and acetone by reductive elimination using an organotin catalyst. The resulting product has a nitro group at the 4 position and can be activated as a priming agent for DNA synthesis. This compound has been shown to be effective in treating intestinal disorders such as ulcerative colitis.
2,3,4-Tri-O-acetyl-a-D-xylopyranosyl bromide - Stabilised with 2.5% CaCO3 has been used to conjugate estrogens with various drugs to create new compounds that are more potent than free estrogens alone. Bioavailability of these conjugates has

2’-(N-Hexadecanoylamino)-4’-nitrophenyl-b-D-galactopyranoside is a synthetic substrate that is used to diagnose and monitor brain diseases. It can be used in the diagnosis of Alzheimer's disease by measuring the amount of amniotic fluid that leaks into the brain. The rate of hydrolysis of this substrate has been shown to be higher in patients with Alzheimer's disease than in healthy controls. This synthetic substrate is also useful for monitoring the activity of taurocholate galactohydrolase, which is an enzyme that breaks down bile salts and plays a role in cholesterol metabolism. The rate of hydrolysis has been found to be increased in patients with Parkinson's disease, but not in those with Alzheimer's disease or healthy controls. 2’-(N-Hexadecanoylamino)-4’-nitrophenyl-b-D-galactop

Valuable chiral building block; rare sugar applied in wood preservation

Glycol ethers are compounds that are used as solvents and plasticizers. They have been shown to inhibit the activity of enzymes, such as glucose-6-phosphate dehydrogenase, which is involved in the conversion of glucose to phosphate. Glycol ethers also promote sugar transport by inhibiting the sodium-dependent glucose transporter (SGLT). This transport mechanism is important for maintaining normal blood sugar levels and preventing diabetic neuropathy. Glycol ethers are also anti-diabetic agents that can increase insulin sensitivity by stimulating insulin release from pancreatic beta cells and improving the response of peripheral tissues to insulin stimulation.

Inhibitor of Man/Glc-dependent lectin binding; used for synthesis of glucoses